CYTEK BIOSCIENCES, INC. (CTKB) Operating margin 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) operating margin by fiscal year — reported operating income divided by reported revenue.
-20.0%FY2025 · since FY2020: 14.7% → -20.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -20.0% | -9.8 pp |
| FY2024 | -10.2% | +4.2 pp |
| FY2023 | -14.4% | -13.3 pp |
| FY2022 | -1.1% | -8.3 pp |
| FY2021 | 7.2% | -7.6 pp |
| FY2020 | 14.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Gross marginCTKB Operating incomeCTKB Operating cash flowCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →